National Comprehensive Cancer Network



About NCCN

Chronic Myelogenous Leukemia Panel - Disclosures as of 11/4/2013

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict Date Completed

Camille N. Abboud, MD

None

ARIAD Pharmaceuticals, Inc.;
Teva

None

None

None

2/11/2015

Mojtaba Akhtari, MD

None

None

None

None

None

5/15/2013

Jessica Altman, MD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Genoptix

None

None

None

2/17/2015

Ellin Berman, MD

None

None

None

None

None

5/23/2014

Peter Curtin, MD

None

None

None

None

None

11/24/2014

Daniel J. DeAngelo, MD, PhD

None

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Sigma-Tau Pharmaceuticals, Inc.

None

None

None

1/27/2015

Michael Deininger, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Gilead

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

ARIAD Pharmaceuticals, Inc.

None

None

5/1/2014

Steven Devine, MD

Genzyme Corporation

GlaxoSmithKline

None

None

None

5/22/2014

Amir T. Fathi, MD

None

Agios Pharmaceuticals;
Seattle Genetics;
Teva Pharmaceuticals

None

None

None

1/20/2015

Lauren Gallagher, RPh, PhD

None

None

None

None

None

12/8/2014

Jason Gotlib, MD, MS

None

Novartis Pharmaceuticals Corporation

None

None

None

3/21/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

9/16/2014

Madan Jagasia, MD

None

None

None

None

None

6/5/2014

Patricia Kropf, MD

None

None

None

None

None

4/9/2014

Joan S. McClure, MS

None

None

None

None

None

12/8/2014

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

None

2/15/2015

Susan O'Brien, MD

Ariad;
Infinity;
Morphosys

Teva

None

None

None

8/27/2013

Arnel Pallera, MD

None

None

None

None

None

5/30/2014

Javier Pinilla-Ibarz, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Cephalon, Inc.;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Pfizer Inc.

None

None

None

9/3/2013

Jerald P. Radich, MD

Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

5/30/2014

Vishnu VB. Reddy, MD

None

None

None

None

None

2/10/2015

Neil P. Shah, MD, PhD

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company

None

None

None

None

2/10/2015

B. Douglas Smith, MD

None

ARIAD Pharmaceuticals, Inc.;
Clavis;
TEVA

None

None

None

2/11/2015

David S. Snyder, MD

Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Bristol-Myers Squibb Company;
Bristol-Myers Squibb Company;
Novartis Pharmaceuticals Corporation

None

None

None

2/10/2015

Hema Sundar, PhD

None

None

None

None

None

2/18/2015

Sarika Trikha, PharmD

None

None

None

None

None

11/11/2014

Meir Wetzler, MD

Bristol-Myers Squibb Company

Teva

None

None

None

7/30/2014